Marion Wealth Management Bristol Myers Squibb CO Transaction History

Marion Wealth Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$72.62 - $79.98 $1.24 Million - $1.37 Million	-17,093 Closed	0 $0
Q1 2022 Apr 08, 2022	BUY	$61.48 - $73.72 $22,194 - $26,612	361 Added 2.16%	17,093 $1.25 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $897,337 - $1.05 Million	16,732 New	16,732 $1.04 Million

2,444

1.51B

29.7M

32.1M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Marion Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Marion Wealth Management with notifications on news.